Abstract:Objective To investigate the correlation between the levels of placenta growth factor (PLGF),soluble angiopoietin receptor-2 (sTie-2) and critical coronary artery plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease (CHD).Methods In three consecutive years from April 2007 to September 2009,a cohort of 719 patients with borderline coronary lesions with stenosis in three main vessels with lumen diameter reduction varied all the way from more than 20％ to less than 70％ and with greater than 2.25 mm of the inner diameter were selected in this study from 4 teaching hospitals of tertiary class A in Beijing.These patients fell into three categories:unstable angina pectoris (UAP,n =292),stable angina pectoris (SAP,n =219) and coronary arteriosclerosis (AS,n =208).The vessels involved were analyzed using quantitative coronary angiography (QCA).Plasma levels of PLGF and sTie-2 were measured by using protein chip.The relationship between plasma levels of vascular factors,sTie-2,PLGF and coronary artery plaque imaging morphology among three groups were analyzed.Results (1) Plasma level of PLGF was 80.33 ng/L in the UAP group,which was significantly higher than 54.29 ng/L in the SAP group and 45.16 ng/L in AS group (both P ＜0.05).Plasma level of sTie-2 was 1353.06 ng/L in the UAP group,which was significantly higher than 1308.28 ng/L in the AS group (P =0.008).(2) There was significantly statistical differences in QCA between the SAP group and the UAP group as well as the AS group (both P ＜ 0.05) in terms of the minimal lumen diameter,diameter stenosis rate,minimal lumen cross-sectional area and cross-sectional area of stenosis.The plaque area in the UAP group was larger than that in the AS group (P =0.013).(3) The relationship between vascular factors and plaque imaging morphology was analyzed.There was significantly statistical difference in the involved lesions among the three groups (P ＜ 0.01).(4) There was a positive correlation between plasma level of PLGF and minimal lumen cross-sectional area (r =0.493,P =0.009).Conclusions The plasma levels of PLGF and sTie-2 reflect the level of neo-vascularization in the plaque,and could be taken as predictive factors for potential pathogenesis of coronary plaque.

[Detection of Plasma Level of Placental Growth Factor from Patients with Coronary Artery Disease].

Detection and Significance of Plasma Placental Growth Factor in Patients with Premature Coronary Heart Disease

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Roles of placental growth factor in percutaneous coronary angioplasty and stent implantation]

[Detection of Visfatin Level of Plasma in Patients with Coronary Artery Diseases].

Study on the Relationship between Soluble Receptor for Advanced Glycation end Products and Coronary Artery Disease in Nondiabetic Patients

Levels Of Pregnancy-Associated Plasma Protein A In Patients With Coronary Artery Disease

Growth differentiation factor 15, ischemia modified albumin and pregnancy-associated plasma protein A in patients with coronary artery disease

Changes and significance of plasma placental growth factor levels in patients with cerebral infarction

A study in the correlation between vascular factors and plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease

Plasma Insulin-Like Growth Factor-ⅰ Level in Acute Coronary Syndrome

Correlation Between Pigment Epithelium-Derived Factor (PEDF) level and Degree of Coronary Angiography and Severity of Coronary Artery Disease in a Chinese Population.

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Plasm N-terminal pro-B-type natriaretic peptide (NT-proBNP) levels and severity of coronary artery lesions in patients with acute coronary syndrome

[Correlation Between Levels of Serum Growth Differentiation Factor-15 and Acute Coronary Syndrome].

The Expressions Of Hgf, Pdgf, Vegf And Angl In Peripheral Arterial Blood And Coronary Artery Blood Of Patients With Acute Coronary Syndromes And The Relationship With Disease Severity

[Relationship Between Placenta Growth Factor and the Pathogenesis of Pregnancy Induced Hypertension Syndrome].

Serum levels and significances of placenta growth factor in patients with different degree of chronic obstructive pulmonary disease

Analysis of Placental Growth Factor in Placentas of Normal Pregnant Women and Women with Hypertensive Disorders of Pregnancy

Clinical value of phosphodiesterase-9A in evaluation of the degree of coronary atherosclerosis

Association Between CD40 Ligands Pregnancy-Associated Plasma Protein-a and Angiographic Morphology of Coronary Lesions in Patients with Coronary Heart Disease